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Mutations in LRPAP1 Are Associated
with Severe Myopia in Humans
Mohammed A. Aldahmesh,1 Arif O. Khan,1,2,10 Hisham Alkuraya,1,3,10 Nouran Adly,1,10
Shamsa Anazi,1,10 Ahmed A. Al-Saleh,4 Jawahir Y. Mohamed,1 Hadia Hijazi,1 Sarita Prabakaran,5
Marlene Tacke,6 Abdullah Al-Khrashi,7 Mais Hashem,1 Thomas Reinheckel,6 Abdullah Assiri,8 and
Fowzan S. Alkuraya1,9,*
Myopia is an extremely common eye disorder but the pathogenesis of its isolated form, which accounts for the overwhelming majority
of cases, remains poorly understood. There is strong evidence for genetic predisposition to myopia, but determining myopia genetic risk
factors has been difficult to achieve. We have identified Mendelian forms of myopia in four consanguineous families and implemented
exome/autozygome analysis to identify homozygous truncating variants in LRPAP1 and CTSH as the likely causal mutations. LRPAP1
encodes a chaperone of LRP1, which is known to influence TGF-b activity. Interestingly, we observed marked deficiency of LRP1 and
upregulation of TGF-b in cells from affected individuals, the latter being consistent with available data on the role of TGF-b in the re-
modeling of the sclera in myopia and the high frequency of myopia in individuals with Marfan syndrome who characteristically
have upregulation of TGF-b signaling. CTSH, on the other hand, encodes a protease and we show that deficiency of the murine ortholog
results in markedly abnormal globes consistent with the observed human phenotype. Our data highlight a role for LRPAP1 and CTSH in
myopia genetics and demonstrate the power of Mendelian forms in illuminating new molecular mechanisms that may be relevant to
common phenotypes.Myopia, or short-sightedness, is a disorder of ocular refrac-
tion in which the eye presents the image anterior to,
rather than exactly at, the plane of the retina, which re-
sults in blurred vision.1 This refractive error is extremely
common in humans with an estimated prevalence of
25% although it can reach 70% or higher in some Asian
populations.2,3 Although myopia is usually a benign disor-
der that can be easily managed with optical means, e.g.,
glasses and contact lenses, individuals with high myopia
are at increased risk of other eye pathologies, most notably
retinal degeneration or even detachment.4 Most cases of
myopia are isolated but there are syndromic forms
that are important to consider clinically, e.g., Stickler
syndrome.5
The etiology of the common isolated form of myopia is
poorly understood but is believed to encompass complex
interaction between genetic and environmental factors,
as is typical of other common phenotypes.5 Myopia can
be induced in animalmodels by inducing excessive accom-
modation.6 In addition, epidemiological data suggest
increasing variability in refraction as young children
grow to become teenagers and young adults, i.e., that
myopia is a developmental process.7 These observations
are the basis of the ‘‘form-deprivation’’ model of myopia,
i.e., projection of blurred images stimulate the elongation
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door activity also increases risk of myopia, an effect that
seems to be mediated by light intensity as suggested by
epidemiological data and animal models.9,10 These impor-
tant environmental factors must be influenced by genetic
factors because myopia is characterized by very high heri-
tability, estimated at 90% by some, and displays strong
familial clustering.11
As is typical of other common phenotypes, genetic risk
factors of myopia have been very difficult to study because
of their complex nature. Conventional linkage analysis has
produced several loci for nonsyndromic myopia, usually
autosomal dominant, but did not reveal causative muta-
tions.12 Similarly, candidate gene association studies have
highlighted a number of genes involved in extracellular
matrix (ECM) remodeling but the biased nature of this
approach limits its utility. More recently, several GWAS sig-
nals have been identified but their effect size is small.5,13,14
An attractive complementary approach would be to study
Mendelian forms of myopia because these tend to bemuch
more tractable and this approach has proven effective in
elucidating novel disease mechanisms for other common
diseases.15,16 Two recent studies from China implemented
next-generation sequencing in families with an apparently
autosomal-dominant form of myopia and identified a
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Figure 1. Identification of LRPAP1Muta-
tions in a Mendelian Form of Myopia
(A) Pedigrees of three consanguineous
families in which extreme myopia appears
to follow an autosomal-recessive mode of
inheritance.
(B) Autozygome analysis shows a single
block of autozygosity (boxed in red, the
coordinates are 1,725,469 to 4,136,325)
on chromosome 4 that is exclusively
shared by the affected members of the
three families (columns represent individ-
ual cases and rows represent individual
SNP calls; black is homozygous and yellow
is heterozygous).
(C) Linkage analysis shows one peak on
chromosome 4 with a LOD score of 7.
(D) Schematic of LRPAP1 and the protein it
encodes with the sites of the two trun-
cating mutations shown. DNA chromato-
grams are shown for the mutations.highlighting them as candidate genes involved in myopia
pathogenesis, although definitive loss-of-function alleles
in these genes have not been identified.17,18 One major
limiting factor in this approach is the availability of such
cases because large effect size variants (causal in the case
of true Mendelian forms) tend to be rare in the general
population.19
We hypothesized that our highly consanguineous
population will be enriched for the otherwise rare occur-
rence of Mendelian forms of myopia.20 Therefore, we set
out to search for families in which consanguineous
healthy parents have children with extreme myopia. We
specifically searched for extreme myopia because
Mendelian forms tend to be more severe and to minimize
the risk of recruiting families with the expected familial
clustering of the common form of myopia. We show that
this approach led to the identification of several families314 The American Journal of Human Genetics 93, 313–320, August 8, 2013in which extreme myopia is indeed
an autosomal-recessive trait probably
caused by fully penetrant inactivating
mutations in two genes, LRPAP1
(MIM 104225) and CTSH (MIM
116820).
All subjects were Saudi children
(2–16 years old) clinically diagnosed
to have extreme myopia (spherical
equivalent of 17 diopters or greater)
that was not related to crystalline lens
subluxation and was not part of
conditions known to be associated
with high myopia (e.g., Stickler syn-
drome, premature birth). Written
informed consent was obtained from
all subjects prior to their enrollment
in this IRB-approved research proto-
col. Four families were identified
in which healthy consanguineousparents had children with extreme myopia (Figures 1
and 2). Best-corrected visual acuity was subnormal; this
decreased visual acuity may have been from amblyopia
and/or chorioretinal atrophy. Clinical findings and
biometric data are summarized in the Table 1.
We mostly recruited multiplex cases with extreme
myopia whose parents are consanguineous in order to
enrich for the possibility of an autosomal-recessive Mende-
lian phenocopy of myopia that is tractable by autozygome
analysis.15,20 Therefore, DNA samples extracted from the
cases and their unaffected siblings and parents were
searched for genome-wide runs of homozygosity (ROH)
>2 Mb in length and >107 SNPs in density, which were
used as surrogates of autozygosity by performing
genome-wide SNP genotyping on Axiom platform
(Affymetrix) that includes >550,000 SNPs followed by
autoSNPa analysis.21
Figure 2. Identification of a CTSH Muta-
tion in a Mendelian Form of Myopia
(A) Pedigree of a consanguineous family
with one child with extreme myopia.
(B) Autozygome analysis shows several
blocks of autozygosity but one block is
shown that harbors CTSH and next to it
is a schematic of the filtration strategy
used to highlight the CTSH mutation.
(C) Schematic of CTSH and the protein it
encodes with the sites of the two trun-
cating mutations shown. DNA chromato-
grams for the reported mutation are
shown.For families 1–3, autozygome analysis revealed only one
autozygous interval that is exclusively shared among all
eight affectedmembers, whichwas later confirmed by link-
age analysis (Figure 1). Although these three families are
not known to be related to one another, haplotype analysis
of the critical autozygous interval in families 2 and 3 was
identical but different from that in family 1. Therefore,
we proceeded with exome sequencing of one affected
member from family 2 and another from family 1. The
only gene that harbored a coding/splicing variant within
the critical autozygous interval that is not reported in
dbSNP build 135 was LRPAP1. Consistent with the haplo-
type analysis result, exome sequencing revealed two
different mutations in family 1 (RefSeq accession number
NM_002337.3; c.605delA) and family 2 (c.863_864del),
and the latter was subsequently found in family 3 by direct
sequencing (Figure 1). Both mutations are truncating in
nature (p.Asn202Thrfs*8 and p.Ile288Argfs*118), fully
segregated with the extreme myopia phenotype in both
families and absent in 210 in-house Saudi exome filesThe American Journal of Humanand publically available SNP data-
bases including the 1000 Genomes
Project (Integrated Phase 1 Release)
and the Exome Variant Server
(ESP6500SI-V2).
In family 4, autozygome analysis of
the index, as expected, revealed
several autozygous regions that were
used to filter the resulting exome var-
iants (Figure 2). Interestingly, a single
variant survived this and the other
filters we applied: a 4 bp deletion
(RefSeq NM_004390.1; c.485_488del)
in CTSH that predicts frameshift and
premature truncation (Figure 2). This
variant was found heterozygous in
the healthy brother and parents and
was absent in 210 in-house Saudi
exome files and publically available
SNP databases including the 1000
Genomes Project (Integrated Phase 1
Release) and the Exome Variant Server
(ESP6500SI-V2). Immunoblot analysisof LRPAP1 revealed absence of the normal protein in
affected individuals with LRPAP1 mutations, whereas RT-
PCR showed marked reduction of the abundance of the
mutant transcription cells from the affected individual
with CTSH mutation compared to controls (90%) when
quantified by real-time RT-PCR (Figure 3), most probably
as a result of NMD. Taken together, our data show that
the mutations in LRPAP1 and CTSH are probably loss-of-
function mutations.
LRPAP1 is a widely expressed gene that encodes Low
Density Lipoprotein Receptor-Related Protein-Associated
Protein 1, a 357 amino acid protein that is thought to act
as a chaperone that binds and protects the lipoprotein re-
ceptor-related proteins LRP1 and LRP2.22,23 It contains
four independently folded domains, D1, D2, D3, and D4,
which encompass residues 1–92, 93–163, 164–216, and
217–323, respectively.24 Because the truncating mutations
we report are predicted to severely truncate the D4 domain
(Figure 1), which is the domain shown experimentally to
be responsible for binding to LRP, we sought to testGenetics 93, 313–320, August 8, 2013 315
Table 1. Clinical Characteristics of Individuals with Autosomal-Recessive Mendelian Phenocopies of Myopia
ID Age Sex Axial Retinoscopy BCVA Mutation Comments
II-8 15 F 35.35 25.00, 3.003060 20/70 LRPAP1: c.605delA
(p.Asn202Thrfs*8)
none
35.37 27.00, 3.003030 20/70
II-9 6 F 32.44 18.50, 5.003150 20/60 LRPAP1: c.605delA
(p.Asn202Thrfs*8)
diaphragm surgery soon
after birth
31.89 14.50, 5.003160 20/60
II-12 16 M 37.65 23.00, 1.003010 20/70 LRPAP1: c.863_864del
(p.Ile288Argfs*118)
left esotropia
37.45 24.75 20/100
II-13 15 F 35.20 23.75, 0.753005 20/100 LRPAP1: c.863_864del
(p.Ile288Argfs*118)
esotropia
35.81 23.50, 1.753150 20/100
II-14 4 M 31.19 20.00 CSM LRPAP1: c.863_864del
(p.Ile288Argfs*118)
exotropia
30.82 20.00 CSM
II-1 7 F 31.55 26.00 20/100 LRPAP1: c.863_864del
(p.Ile288Argfs*118)
esotropia
30.95 26.00 20/100
II-1 4 M 29.64 23.50 CSM LRPAP1: c.863_864del
(p.Ile288Argfs*118)
none
29.80 23.00 CSM
II-3 2 M NA 19.00 CSM LRPAP1: c.863_864del
(p.Ile288Argfs*118)
intermittent
NA 19.00 CSUM esotropia
F4 1 M 27.60 17.00 CSM CTSH: c.485_488del phthisis bulbi in the other
eye, dysmorphia
Where relevant for a given individual, first row refers to right eye and second row to left eye. Age is given in years. Sex is indicated as ‘‘M’’ for male and ‘‘F’’ for
female. Retinoscopy in given in diopters after cyclopentolate 1% (first number is the sphere and second number is the cylinder [indicating astigmatism] followed
by the axis). Abbreviations are as follows: BCVA, best-corrected visual acuity; NA, not able to be performed because of young age; CSM, central steady and main-
tained fixation; CSUM, central steady and unmaintained fixation.whether these mutations may abolish the chaperone activ-
ity and result in increased degradation of LRP1. Indeed,
immunoblot analysis revealed that cells from affected indi-
viduals have marked reduction in LRP1 compared to con-
trols (Figure 4).
LRP1 is identical to TGF-bR(V) butmice deficient in LRP1
have paradoxically activated TGF-b signaling.25 This is not
surprising because mutations in TGF-b2, TGF-bR(I), and
TGF-bR(II) are also known to result in a paradoxical activa-
tion of TGF-b, giving rise to a Marfan-like phenotype
(Marfan syndrome itself is characterized by increased
TGF-b).26–29 Therefore, we wanted to test whether TGF-b
is increased in cells with LRPAP1 truncation. Indeed,
more than 2-fold increase in TGF-b level was observed
(Figure 4). Interestingly, TGF-b is one of themost reproduc-
ibly dysregulated genes in the study of myopia develop-
ment and is thought to exert an effect throughmodulating
ECM of the sclera, thereby allowing the eye to increase in
axial length in response to ‘‘form deprivation.’’30
CTSH encodes 1 of 11 papain-like cysteine proteases,
known as cysteine-cathepsins, existing in humans.31316 The American Journal of Human Genetics 93, 313–320, August 8Active cathepsin H (CTSH) is a 37 kD protein that possesses
both endo- and exopeptidase function.32,33
Although Ctsh has a ubiquitous expression pattern,
there has been recent interest in exploring a potential
nonredundant role in specific cell and tissue types. Gene
targeting of Ctsh in mice established roles for this protease
in the processing of the surfactant-glycoprotein SP-B in
pneumocytes, in coactivation of granzyme B in lympho-
cytes, in N-terminal trimming of pituitary gland neuropep-
tides, as well as in tumor growth and angiogenesis in
neuroendocrine pancreatic tumors.34–38 However, no
severe general phenotype was observed in these Ctsh
knockout mice and the eye has not been studied so far.
Therefore, we asked whether CTSH deficiency recapitulates
the eye-specific phenotype we observed in the affected in-
dividuals. Remarkably, Ctsh/ eyes displayed markedly
abnormal posterior chamber that assumes a ‘‘<’’ configura-
tion compared to the rounded appearance in wild-type lit-
termates, a pattern suggestive of abnormal lengthening,
similar to that observed in the affected individuals
(Figure 5)., 2013
Figure 3. LRPAP1 and CTSH Mutations Are Probably Loss of
Function
(A) Immunoblot analysis with LRPAP1 antibody shows nearly
complete loss of LRPAP1 in the index of each of families 1–3
compared to controls.
(B) RT-PCR of two cDNA fragments from CTSH (Rx1 and Rx2)
shows severe instability of the mutant transcript in the index in
family 4 compared to control.
Figure 4. LRPAP1 Deficiency Is Associated with Severe Deple-
tion of LRP1 and Upregulation of TGFB1
Top: immunoblot analysis with LRP1 antibody showing marked
reduction of the band corresponding to LRP1 in affected individ-
uals compared to controls (GAPDH is shown for loading control).
Bottom: immunoblot analysis with TGF-b antibody showing
>2-fold increase in TGF-b in affected individuals compared to con-
trols (GAPDH is shown for loading control).Deciphering the genetics of myopia is complicated by
the same set of challenges that are usually seen in other
multifactorial disorders.39 Despite these challenges,
research continues into myopia genetics because it is
hoped that identifying genetic risk factors will illuminate
the molecular pathogenesis of this extremely common
disorder and make it possible to consider potential targets
for prevention or therapy. Although Mendelian forms of
multifactorial disorders are rare, they lend themselves
readily to the same powerful tools of gene mapping
that made the field of Mendelian genetics very successful.
More importantly, by identifying a single lesion in a
genetically homogeneous cohort, one can assign causal-
ity more confidently and direct resources to the under-
standing of the underlying mechanism that may inform
our understanding of the pathogenesis of the multifacto-
rial counterpart. Indeed, we show that pursuit of rare
Mendelian forms of myopia identified two genes previ-
ously unsuspected as playing a role in axial length deter-
mination.
Our study suggests a model wherein LRPAP1 deficiency
leads to deficiency of LRP1, which we propose leads to
perturbation of TGF-b regulation and may result in
abnormal ECM remodeling in the developing eye. This
model is supported by the observation that myopia caused
by increased axial length is one of the characteristic fea-The Amertures of Marfan syndrome, which is also characterized by
increased TGF-b.40,41 Lack of other Marfan features in the
study individuals can be due to several factors including
divergence in other aspects of the molecular pathogenesis.
Although it remains to be seen how generalizable our find-
ings are to common myopia, they provide supportive
evidence of the role of TGF-b signaling in myopia develop-
ment in humans. Various manifestations of Marfan syn-
drome have been shown to respond to treatment with
antagonists of TGF-b but it remains to be seen whether
myopia in these individuals responds to this therapeutic
strategy, especially if initiated early before unfavorable
ECM remodeling takes place.41 If it does, it will be of inter-
est to consider this approach in individuals with LRPAP1-
related myopia.
Although the level of evidence is less robust when
compared to LRPAP1 because we have only one human
mutation, our study strongly supports a causal link be-
tween CTSH deficiency and severe myopia development
and reveals a role for a cathepsin in the axial length deter-
mination. First, the mutation we identified is the only
sequence variant that survived the various filters we
applied in the interpretation of the thousands of exome-
generated variants.42 Second, the mutation is truncating
in nature and our RNA analysis supports severe deficiency
as a result. Third, we show that mice deficient in its ortho-
log have markedly abnormal globe suggestive of increased
axial length. The mechanism by which this protease mod-
ifies axial length developmentally remains unknown but is
likely to involve modification of the ECM. We note here
that mutations in another protease, PRSS56, cause an
almost mirror image of myopia with severe shortening of
the axial length in a condition known as posterior micro-
phthalmos.43–45ican Journal of Human Genetics 93, 313–320, August 8, 2013 317
Figure 5. CTSH Deficiency in Mouse Results in Abnormal Globe
Development
A panel of comparable eye H&E-stained sections from Ctsh/ and
their wild-type littermate (four animals are shown, two eyes each
for a total of eight sections). Note the grossly abnormal globes in
the knockout mouse that assume a ‘‘<’’ shape compared to the
rounded appearance in controls, most probably indicative of elon-
gated axial length.How much, if at all, does variation in CTSH and LRPAP1
influence the common form of myopia? The LRPAP1
locus has not been highlighted in any GWAS on myopia
in the past. On the other hand, we note that CTSH is in
remarkable proximity to RASGRF1 (45 kb away), which
was reported recently as the source of a major association
signal in a GWAS (and replicated by two others) on
myopia even though the mouse phenotype is not consis-
tent with its presumed role in myopia pathogen-
esis.13,14,46 We have sequenced CTSH and LRPAP1 in a
panel of 100 individuals with myopia of R6 D but did
not find any evidence of increased load of rare variants
in these individuals compared to 100 similarly screened
controls (data not shown). Thus, it remains to be seen
whether these genes, especially CTSH, are directly
involved in the pathogenesis of the common form of
myopia although the pathways involved may be logical
targets for future studies.318 The American Journal of Human Genetics 93, 313–320, August 8In summary, we present two recessive Mendelian
forms of myopia that are solved at the gene level.
The nature of the two genes identified in this study
suggests a role of ECM remodeling in myopia develop-
ment through TGF-b signaling and protease-mediated
pathways. Although we could not find evidence for
increased load of rare or common variants in LRPAP1 or
CTSH in individuals with the common form of myopia,
future studies are needed to fully explore a potential role
their pathways may play in the pathogenesis of common
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